Want to see JP:4889 full AI Analyst Report?
Total Valuation
Renascience Inc. has a market cap or net worth of ¥20.46B. The enterprise value is ¥18.70B.
Market Cap¥20.46B
Enterprise Value¥18.70B
Share Statistics
Renascience Inc. has 13,776,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,776,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Renascience Inc.’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -10.74%.
Return on Equity (ROE)-0.09
Return on Assets (ROA)-0.09
Return on Invested Capital (ROIC)-10.74%
Return on Capital Employed (ROCE)-0.11
Revenue Per Employee22.85M
Profits Per Employee-100.43M
Employee Count3
Asset Turnover0.02
Inventory Turnover362.17
Valuation Ratios
The current PE Ratio of Renascience Inc. is ―. Renascience Inc.’s PEG ratio is 0.20.
PE Ratio―
PS Ratio315.22
PB Ratio6.50
Price to Fair Value6.50
Price to FCF-74.18
Price to Operating Cash Flow0.00
PEG Ratio0.20
Income Statement
In the last 12 months, Renascience Inc. had revenue of 68.55M and earned -301.28M in profits. Earnings per share was -23.39.
Revenue68.55M
Gross Profit64.21M
Operating Income-356.88M
Pretax Income-300.27M
Net Income-301.28M
EBITDA-356.88M
Earnings Per Share (EPS)-23.39
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Renascience Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.86
52-Week Price Change-48.85%
50-Day Moving Average1.54K
200-Day Moving Average1.66K
Relative Strength Index (RSI)47.92
Average Volume (3m)312.67K
Important Dates
Renascience Inc. upcoming earnings date is Aug 14, 2026, TBA (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateAug 14, 2026
Ex-Dividend Date―
Financial Position
Renascience Inc. as a current ratio of 19.40, with Debt / Equity ratio of 0.00%
Current Ratio19.40
Quick Ratio19.40
Debt to Market Cap0.00
Net Debt to EBITDA9.53
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Renascience Inc. has paid 1.00M in taxes.
Income Tax1.00M
Effective Tax Rate>-0.01
Enterprise Valuation
Renascience Inc. EV to EBITDA ratio is -51.02, with an EV/FCF ratio of -62.50.
EV to Sales265.58
EV to EBITDA-51.02
EV to Free Cash Flow-62.50
EV to Operating Cash Flow-62.50
Balance Sheet
Renascience Inc. has ¥3.40B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of ¥3.40B billion.
Cash & Marketable Securities¥3.40B
Total Debt¥0.00
Net Cash¥3.40B
Net Cash Per Share¥246.99
Tangible Book Value Per Share¥258.01
Margins
Gross margin is 93.66%, with operating margin of -520.59%, and net profit margin of -439.47%.
Gross Margin93.66%
Operating Margin-520.59%
Pretax Margin-438.01%
Net Profit Margin-439.47%
EBITDA Margin-520.59%
EBIT Margin-520.59%
Analyst Forecast
The average price target for Renascience Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-48.34%
EPS Growth Forecast-361.92%